New driver mutations in non-small-cell lung cancer.

Abstract excerpt

Treatment decisions for patients with lung cancer have historically been based on tumour histology. Some understanding of the molecular composition of tumours has led to the development of targeted agents, for which initial findings are promising. Clearer understanding of mutations in relevant genes and their effects on cancer cell proliferation and survival, is, therefore, of substantial interest. We review...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Receptor, ErbB-2
• Share to Adaptor Proteins, Signal Transducing
• Share to Anaplastic Lymphoma Kinase